Your English writing platform
Discover LudwigExact(2)
Local recurrence occurred in 32 patients (33% of Type I recurrence cases, 29% of Type II recurrence cases) at the tumour bed including the mediastinum and oesophago-jejunal or oesophago-gastric anastomosis.
So, at TNM stage I recurrence was observed for just one patient and no deaths were reported, while stage II patients show percentages of tumour recurrence and death of 17.5% and 12.5% respectively, with mean DFS and OS of 55.73 and 58.55 months.
Similar(58)
We set two survival end points: (i) recurrence-free survival (RFS) was defined as the time from surgery until the date of disease recurrence, and (ii) breast cancer-specific survival (BCSS) was defined as the time until death due to breast cancer.
The most frequent type of recurrence was haematogenous (56% of Type I recurrences and 54% of Type II) of which 56% were detected within 1 year of surgery.
Table 1 Is recurrence attack- or patient-dependent?
We aim to: (i) evaluate recurrence risks for breech presentation at term, and (ii) assess risk factors that contribute to the recurrence.
The medical records of the patients were thoroughly checked and for those who were suffering from ileocecal junction tumors or anal canal tumors and those with any of the following conditions: i. recurrence of CRC; ii.
Nine additional patients were treated with I after recurrence.
DFS includes the events (i) regional recurrence of breast cancer, (ii) distant metastasis and (iii) contra lateral breast cancer.
The models described here possess, e.g., regimes of i) tumor recurrence, ii) transiently constant tumor size, iii) quasi-chaotic behavior.
For subject i, the recurrence times t i 1, t i 2, …, t i K were generated as correlated Weibull deviates as is explained below.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com